title: Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin.
abstract: Disseminated strongyloidiasis is a disease with high mortality rate, especially in immunocompromised individuals. Paralytic ileus and intestinal malabsorption are frequent symptoms caused by this severe disease. As there are no licensed parenteral anthelmintic drugs for human use, off-label formulations are often used in the treatment of this disease. In this case report, the use of subcutaneous ivermectin is described as a successful therapy for this life-threatening infection.
authors.affiliation: Hospital Santa Luzia, Brasília, Brazil. ebmoura@terra.com.br
authors.forename: Edmilson Bastos de
authors.initials: EB
authors.lastname: Moura
authors.forename: Marcelo de Oliveira
authors.initials: Mde O
authors.lastname: Maia
authors.forename: Monalisa
authors.initials: M
authors.lastname: Ghazi
authors.forename: Fábio Ferreira
authors.initials: FF
authors.lastname: Amorim
authors.forename: Henrique Marconi
authors.initials: HM
authors.lastname: Pinhati
mesh_terms: D000818:Animals; D000977:Antiparasitic Agents / Q000008:administration & dosage*; D006801:Humans; D016867:Immunocompromised Host; D007559:Ivermectin / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D016879:Salvage Therapy; D017171:Strongyloides stercoralis; D013322:Strongyloidiasis / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000977:Antiparasitic Agents; D007559:Ivermectin